2024-12-14 03:24:08
Among them, the biggest benefit is the biomedical industry. It is necessary to set up a M&A fund with a scale of 10 billion, which is specifically aimed at the merger and reorganization of the biomedical industry! The focus is on local enterprises in Shanghai, especially the biomedicine of listed companies in Shanghai.However, it is a great pity that the China stock market has never had a history of retail investors and institutions getting rich together. Don't deal with hot money and quantification! Foreign investment in A-shares has also become stale and has become fond of speculation. There are always too many routines to create A shares, which is too tiring to play, and the experience is really bad.True Vision: The controlling shareholder and others intend to reduce their holdings by 4% in total;
Let's talk about some encouraging and unintelligent observations. Now the main purpose of everyone's smashing is to adjust positions, not to sell them back. This is the biggest difference from the past few years! Explain that regardless of retail investors, institutions and foreign investors, they still believe in the A-share bull market.Second, Contemporary Amperex Technology Co., Limited's enlargement trick: special dividends for factories in Europe
Second, Contemporary Amperex Technology Co., Limited's enlargement trick: special dividends for factories in EuropeFirst, heavy! Shanghai merger and reorganization action plan announcedNews:
Strategy guide 12-14
Strategy guide
Strategy guide
12-14